Muscle-derived interleukin-6: Mechanisms for activation and possible biological roles

FASEB Journal

Volumn 16, Issue 11, 2002, Pages 1335-1347

  Febbraio, Mark A ^a,c   Pedersen, Bente Klarlund ^a,b,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Rigshospitalet   (Denmark)

Author keywords

Calcium; Cytokines; Glycogen; Intracellular signaling; Lipolysis; Metabolic syndrome; Metabolism

Indexed keywords

CALCIUM ION; INTERLEUKIN 6;

ANIMAL CELL; ATHEROSCLEROSIS; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EXERCISE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOASSAY; INSULIN TREATMENT; METABOLIC REGULATION; MOUSE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STIMULUS RESPONSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE; GLYCOGEN; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; MODELS, BIOLOGICAL; MONOCYTES; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036720342     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0876rev     Document Type: Review

References (141)

1. Exercise and the immune system: Regulation, integration and adaption
2. Muscle-derived interleukin-6: Possible biological effects
3. Evidence that IL-6 is produced in skeletal muscle during intense long-term muscle activity
4. A trauma-like elevation in plasma cytokines in humans in response to tread-mill running
5. The cytokine balance and strenuous exercise: TNF-alpha, IL-2β, IL-6, IL-1ra, sTNF-r1, sTNF-r2, and IL-10
6. Chemokines are elevated in plasma after strenuous exercise
7. The cytokine response to strenuous exercise
8. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running
9. The effects of n-3 PUFA on the cytokine response to strenuous exercise
10. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans
11. Leukemia inhibitory factor. Interleukin 6, and other cytokines using the GP130 transducing receptor: Roles in inflammation and injury
12. IL-6 cytokine family and signal transduction: A model of the cytokine system
13. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily
14. Interleukin-6 in biology and medicine
15. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli
16. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6
17. Hypoxemia increases serum interleukin-6 in humans
18. Interleukin-6 response to exercise and high altitude exposure: Influence of alpha-adrenergic blockade
19. Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-alpha, in vivo
20. Immunologic mediators as parameters of the reaction to strenuous exercise
21. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running
22. Bicycle exercise enhances plasma IL-6 but does not change IL-1alpha. IL-1beta:IL-6, or TNF-alpha pre-mRNA in BMNC
23. Endurance run increases circulating IL-6 and IL-1ra but down-regulates ex vivo TNF-alpha and IL-1beta production
24. Carbohydrate and the cytokine response to 2.5 hours of running
25. Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation
26. Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6
27. Xanthine oxidase in human skeletal muscle following eccentric exercise: A role of inflammation
28. Effects of mode and carbohydrate on the granulocyte and monocyte response to intensive prolonged exercise
29. Carbohydrate ingestion attenuates the increase in plasma interleukin 6, but not skeletal muscle interleukin 6 mRNA, during exercise in humans
30. Production of IL-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma IL-6
31. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content
32. Plasma interleukin-6 during strenuous exercise - Role of adrenaline
33. The effects of n-3 PUFA on the cytokine response to strenuous exercise
34. Lymphocytes and NK cell activity during repeated bouts of maximal exercise
35. Physical activity and plasma interleukin-6 in humans - Effect of intensity of exercise
36. Influence of mode and carbohydrate on the cytokine response to heavy exertion
37. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content
38. Exercise-induced immunomodulation - Possible roles of neuroendocrine factors and metabolic factors
39. Exercise-induced increase in interleukin-6 is related to muscle damage
40. Effects of training on exercise-induced muscle damage and interleukin 6 production
41. The cytokine response to eccentric exercise in young and elderly humans
42. Carbohydrate and the cytokine response to 2.5 h of running
43. Intracellular monocyte and serum cytokine expression is modulated by exhausting exercise and cold exposure
44. Induction of plasma interleukin-6 by circulating adrenaline in the rat
45. Effect of prolonged submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans
46. Lack of IL-6 production during exercise in patients with mitochondrial myopathy
47. Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear
48. Muscle contractions induces interleukin-6 mRNA production in rat skeletal muscles
49. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts
50. Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation
51. Novel path to activation of vascular smooth muscle cells: Up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor
52. IL-6 production in various types of tissues as measured by microdialysis in response to exercise in humans
53. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies
54. Endocrine and carbohydrate responses to interleukin-6 in vivo
55. Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools
56. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver
57. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver
58. Effect of carbohydrate ingestion on glucose kinetics during exercise
59. Glucose kinetics during prolonged exercise in highly trained human subjects: Effect of glucose ingestion
60. Effect of increased blood glucose availability on glucose kinetics during exercise
61. Endocrinologic and metabolic effects of interleukin-6 in humans
62. Remodeling muscles with calcineurin
63. 2+ dependent pathway
64. Inositol trisphosphate and calcium signalling
65. Calcium signaling in neurons: Molecular mechanisms and cellular consequences
66. Calcium oscillations increase the efficiency and specificity of gene expression
67. Transcription factors of the NFAT family: Regulation and function
68. 2+, calcineurin, and NF-AT
69. Marathon running transiently increases c-Jun NH2-terminal kinase and p38 activities in human skeletal muscle
70. Extracellular-regulated kinase 1/2. Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes
71. Carbohydrate ingestion during prolonged exercise: Effects on metabolism and performance
72. Special feature for the Olympics: Effects of exercise on the immune system: Modification of immune responses to exercise by carbohydrate, glutamine and anti-oxidant supplements
73. Effects of exercise of varying duration on sarcoplasmic reticulum function
74. 2+] in the development of low frequency fatigue in mo use single muscle fibres
75. Glycogen content and excitation-contraction coupling in mechanically skinned muscle fibres of the cane toad
76. Impaired calcium pump function does not slow relaxation in human skeletal muscle after prolonged exercise
77. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system
78. Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts
79. Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity
80. From receptor to transporter: Insulin signalling to glucose transport
81. Interleukins and exercise
82. Glucose metabolism during leg exercise in man
83. Hepatic glucose production during exercise
84. Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component
85. Glucose counter regulation: Prevention and correction of hypoglycemia in humans
86. Glucose production during strenuous exercise in humans: Role of epinephrine
87. Glucoregulation during and after intense exercise: Effects of alpha-adrenergic blockade
88. Glucoregulation during and after intense exercise: Effects of beta-blockade
89. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes
90. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation
91. Molecular cloning and characterization of an insulin-regulatable glucose transporter
92. Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution
93. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
94. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation
95. Effect of exercise on glucose disposal: Response to a maximal insulin stimulus
96. 2+ ionophore ionomycin on insulin-stimulated and basal glucose transport in muscle
97. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin
98. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport
99. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport
100. Effect of AMPK activation on muscle glucose metabolism in conscious rats
101. Glucose, exercise and insulin: Emerging concepts
102. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle
103. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes
104. Effect of proinflammatory interleukins on jejunal nutrient transport
105. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase
106. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans
107. Interleukin-6 stimulates hepatic triglyceride secretion in rats
108. Interleukin-6-deficient mice develop mature-onset obesity
109. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
110. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man
111. Interleukin-6 production in human subcutaneous tissue. The effect of exercise
112. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
113. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
114. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
115. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline
116. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
117. Mohammed-Ali (2000) Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
118. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
119. C. reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
120. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections
121. Cytokines and type 2 diabetes1 mellitus
122. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
123. Sleep Apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia
124. The expression of TNF alpha by human muscle. Relationship to insulin resistance
125. Effects of tumor necrosis factor-beta on insulin action in cultured human muscle cells
126. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha
127. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
128. The role of TNFalpha and TNF receptors in obesity and insulin resistance
129. Interleukin-6 gene polymorphism and insulin sensitivity
130. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
131. Ageing, tumour necrosis factor-alpha (TNT-alpha) and atherosclerosis
132. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
133. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages
134. Overexpression of interleukin-6 aggravates viral myocarditis: Impaired increase in tumor necrosis factor-alpha
135. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
136. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia and cytokine release in D-galactose-sensitized and unsensitized mice
137. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6
138. Strenuous exercise decreases the percentage of type 1 T cells in the circulation
139. Insulin action and insulin resistance in human skeletal muscle
140. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice
141. Interleukin-6 expression in insulin-resistant rodent skeletal muscle